Alnylam Pharmaceuticals Inc's drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the first approved treatment from a new class of medicines that use gene silencing technology.



Latest News

Daily Mail: Hunt for hit-and-run driver who killed California beauty queen mother of two at a crosswalk

Daily Mail: Ronnie O´Sullivan claims 15th maximum break of career...

Daily Mail: MLB clears Astros of wrongdoing in sign-stealing...

Daily Mail: Chile to seek international arbitration over Albemarle...

Daily Mail: EMERGING MARKETS-Strong dollar knocks most Latam FX,...

Daily Mail: Cardi B BLASTS report claiming she is releasing Nicki Minaj diss track one month after shoe incident

Daily Mail: PulteGroup, IBM and Fiat Chrysler fall while Netflix...

Daily Mail: Minnesota House hopeful calls marriage, fraud claims...

Daily Mail: Mel B rocks skintight nude co-ords as she goes shopping in LA

Daily Mail: Beech sapling grown into letter 'N' is named England's Tree of the Year 

CNBC: Full interview with Leon Cooperman

CNBC: Full interview with Jeff DeGraaf

CNBC: Constellation Brands CEO Rob Sands will step down in March: WSJ

NBC New York: Video Shows Mom Smuggling Drugs Into Rikers in Baby's Diaper

NBC New York: NYC: 6 Children in Brooklyn Diagnosed With Measles

CTV News: Poll finds 71 per cent of Canadians are not interested in smoking cannabis

Reuters: May seeks to reassure EU leaders on Brexit deal

Reuters: Aluminum producer Alcoa posts quarterly loss on pension charge

Reuters: UPDATE 2-Wooing investors, Rwanda hosts first tantalum-tracking blockchain

Reuters: Aluminum producer Alcoa posts quarterly loss on pension charge

Haaretz: Gaza escalation: Netanyahu and Lieberman are talking Israel into a corner

WashingtonPost: Jerry Jones praises Roger Goodell, a year after trying to oust him as NFL commissioner

WashingtonPost: Maryland basketball gets ready for season touting the promise of its youth

12 Related Articles, between 2018-08-10 and 2018-08-08